Pharmaceutical company funding and its consequences: A qualitative systematic review. Sismondo, S. Contemporary Clinical Trials, 29(2):109–113, March, 2008. 1
Pharmaceutical company funding and its consequences: A qualitative systematic review [link]Paper  doi  abstract   bibtex   
This article systematically reviews published studies of the association of pharmaceutical industry funding and clinical trial results, as well a few closely related studies. It reviews two earlier results, and surveys the recent literature. Results are clear: Pharmaceutical company sponsorship is strongly associated with results that favor the sponsors' interests.
@article{sismondo_pharmaceutical_2008,
	title = {Pharmaceutical company funding and its consequences: {A} qualitative systematic review},
	volume = {29},
	issn = {1551-7144},
	shorttitle = {Pharmaceutical company funding and its consequences},
	url = {http://www.sciencedirect.com/science/article/pii/S1551714407001255},
	doi = {10.1016/j.cct.2007.08.001},
	abstract = {This article systematically reviews published studies of the association of pharmaceutical industry funding and clinical trial results, as well a few closely related studies. It reviews two earlier results, and surveys the recent literature. Results are clear: Pharmaceutical company sponsorship is strongly associated with results that favor the sponsors' interests.},
	number = {2},
	urldate = {2018-01-31},
	journal = {Contemporary Clinical Trials},
	author = {Sismondo, Sergio},
	month = mar,
	year = {2008},
	note = {1},
	keywords = {5 Ignorance and manufactured doubt, 8 Ignorance and funding bias, Bias, Ignorance et mécanismes de production du doute, Industry funding, PRINTED (Fonds papier), Pharmaceutical companies, Sponsorship},
	pages = {109--113},
}

Downloads: 0